Vincristine Sulfate
Records for this ingredient, by country (identity only).
ATC L01CA02 · 4 markets · 27 records
AU 20 records · 4 shown of 4
- 1 mg/mL per mL / per unit basis not statedinjectionHospira Vincristine Solution Injection, 2 mg/2 mL vialHospira Vincristine Sulfate 2 mg/2 mL injection USP、HOSPIRA VINCRISTINE SULFATE 5mg/5mL Injection Vial、Hospira Vincristine Sulfate Injection USP 1 mg/1 mL Vial、Hospira Vincristine Sulphate 5 mg/5 mL Injection vial (preserved)、Hospira Vincristine Sulphate Injection, 2 mg/2 mL vial、Pfizer (Australia) VINCRISTINE SULFATE 1mg/1mL injection vial、Pfizer Vincristine Sulfate 1 mg/1 mL solution for injection vial、Pfizer Vincristine Sulfate Injection 2 mg/2 mL vial
- 2 mg/mL per mL / per unit basis not statedinjectionPfizer Vincristine Sulfate 1 mg/1 mL solution for injection vial
- 1 mg per mL / per unit basis not statedinjectionONCOVIN vincristine sulfate 1mg powder for injection vial
- 1 mgunknownONCOVIN 1mg powder for injection with diluent
HK 3 records · 0 shown of 0
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名VINCRISTINE SULFATE FOR INJ 1MG ×1VINCRISTINE SULPHATE PHARMACHEMIE INJ 1MG/ML ×1VINRACINE INJ. 1 mg/ml ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 3 records · 2 shown of 2
- 1 mg/1 mLinjectionONCOVIN 1 mg, solution injectableVINCRISTINE TEVA 1 mg/ml, solution injectable
- 2 mg/2 mLinjectionVINCRISTINE HOSPIRA 2 mg/2 ml, solution injectable
SG 1 records · 1 shown of 1
- 1 mg/mL per mL / per unit basis not statedinjectionVINRACINE INJ. 1 mg/ml
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.